Transcatheter Heart Valve Replacement Market to hit $10.5 billion by 2025: Global Market Insights, Inc.

United States dominated the North America transcatheter heart valve replacement market and was valued more than USD 1,711 million in 2018 owing to growing number of people suffering from valvular heart disease in the country along with favorable reimbursement policies.


Sellbyville, Delaware, March 20, 2019 (GLOBE NEWSWIRE) --

Germany dominated the Europe transcatheter heart valve replacement market and was valued around USD 348.1 million in the year 2018. Germany has been among the prominent nations accosts the globe in carrying out heart valve implantation procedures. Tremendous evolution in the past few years in transcatheter heart valve replacement in the country has resulted in growing demand and rapid adoption of the device, fueling the business growth.

Global Transcatheter Heart Valve Replacement Market will surpass USD 10.5 billion by 2025; according to a new research study published by Global Market Insights, Inc. Rising capital investment for the transcatheter heart valve devices by major market players is one of the primary factors augmenting the growth of the market in North America and Europe. For instance, Abbott laboratories; a global healthcare leader announced its investment in manufacturing of Portico transcatheter valve. Hence, venture capital investment in the production of transcatheter heart valve devices by major players in the healthcare sector will be a market driver in North America and Europe.

Valvular diseases are an emerging epidemic in most of the Asia Pacific countries. The prevalence of cardiac diseases is considerably high in China and India and has increased gradually over the past few years. Also, there is rise in quality of treatment offered to the patients. The enhancements in the valvular disease care and increasing awareness related to the transcatheter heart valve replacement devices may lead to boosting the business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3170

Lack of awareness among the people in the Middle East and Africa region about the latest medical facilities is the primary drawback in the growth of the transcatheter heart valve replacement market. Most countries in the MEA region spend more on defense than on research and development and healthcare. Hence, healthcare industry in few of the MEA regions are lagging behind on primary indices of development.

Browse key industry insights spread across 350 pages with 710 market data tables & 12 figures & charts from the report, “Transcatheter Heart Valve Replacement Market Size By Product (Transcatheter Aortic Valve, Transcatheter Mitral Valve {Mitral Valve Repair, Mitral Valve Replacement}, Transcatheter Pulmonary Valve), By Surgical Approach (Transfemoral Approach, Transapical Approach, Transaortic Approach), By Application (Aortic Valvular Heart Disease {Aortic Valve Stenosis, Aortic Valve Regurgitation}, Mitral Valvular Heart Disease {Mitral Valve Stenosis, Mitral Valve Regurgitation}, Pulmonary Valvular Heart Disease) By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Ireland, Norway, Poland, Portugal, Sweden, Switzerland, Netherlands, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/transcatheter-heart-valve-replacement-market

Transcatheter pulmonary valve replacement market was valued around USD 471.3 million in the year 2018. Increase in number of patients with narrowed or leaky pulmonary valve, specifically after surgical replacements are advised with transcatheter pulmonary valve replacement procedures. Hence, increase in pulmonary valvular disease will augment the growth of transcatheter heart valve replacement market in the future.

Transapical approach market is estimated to grow at a CAGR of 14.1% over the projection period. This approach is specifically used for the valve-in-valve implantation in mitral bio prosthesis and valve in ring implantation in annuloplasty rings for patients suffering from acute mitral regurgitation. Rise in prevalence of mitral valvular disease will enhance the growth of transcatheter heart valve replacement market in the upcoming years.

Application of transcatheter heart valve in pulmonary valvular heart disease was valued around USD 294.2 million in the year 2018. Increase in prevalence of pulmonary heart valvular disease among the neonates will be a major market driving factor.

The use of transcatheter heart valve in ambulatory surgical centers is estimated to grow at 14.1% over the forecast period. The ambulatory surgical centers are healthcare facilities that perform minimally invasive surgeries and that does not require hospitalization of the patient for a long time. Hence, increase in demand for minimally invasive surgeries in the ambulatory surgical centers will augment the business growth.

Some of the key industry players operating in global neonatal ventilator market are Medtronic Plc, Edwards Lifesciences, Boston Scientific, Abbott. The industry players are majorly focusing on new product developments, new product launches, mergers and acquisitions and geographical expansion in order to increase their foothold in the market and gain competitive advantage.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3170

Browse Related Reports:

Heart Pump Devices Market Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, India, China, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024

https://www.gminsights.com/industry-analysis/heart-pump-devices-market

Ventricular Assist Devices Market By Product [Left ventricular assist devices (LVADs), Right ventricular assist devices (RVADs), Biventricular assist devices (BIVADs), Percutaneous Ventricular Assist Devices, Total Artificial Heart], By Application [Destination therapy, Bridge-to-candidacy (BTC) therapy, Bridge-to-transplant (BTT) therapy, Bridge-to-recovery (BTR) therapy], By Age [Below 18, 19-39, 40-59, 60-79, Above 80] Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024       

https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


            

Contact Data